GlaxoSmithKline Pharmaceuticals
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others.
| Company type | Public |
|---|---|
Traded as | BSE: 500660 NSE: GLAXO |
| Industry | Pharmaceuticals & healthcare |
| Predecessor | Laboratories (I) Ltd |
| Founded | 13 November 1924 as H. J. Foster & Co. Limited |
| Headquarters | Mumbai, Maharashtra , India |
| Products | Medicines and vaccines |
| Revenue | ₹3,309 crore (US$410 million) (FY 2021) |
Net income | ₹358 crore (US$45 million) (FY 2021) |
Number of employees | 3500 |
| Parent | GSK |
| Website | india-pharma |
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.